gift nifty image banner
Latest News

USFDA approves Zydus Cadila’s hypertension medicine Pindolol

On Tuesday, Zydus Cadila has said that it has got the final approval from the US health regulator for marketing Pindolol tablets that are used in treating hypertension.

Zydus Cadila has said in a BSE filing that the company has received approval from the US Food and Drug Administration (USFDA)Β  to market the drug in the strengths of 5 mg and 10 mg.

The company has said that it is going to manufacture the drug at the group’s manufacturing facility at the Pharma SEZ in Ahmedabad.

Read EquityPandit’s Technical Analysis on Nifty Pharma

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ’Ό
Portfolio 2026
Get 1-2 Index Option Trades Daily